Robey, Robert W.
National Cancer Institute (NCI),
United States
2025 Rank: 162548
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 6004 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162548 | 169568 |
| Total Cites | 13564 | 15583 |
| H-index | 61 | 67 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 3812 | 4208 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 3838 | 4239 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9556 | 10143 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.54 |
| Self-Citation Percentage |
12.96%
|
|
Robey, Robert W.
National Institutes of Health (NIH),
United States
2024 Rank: 156159
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 5853 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 156159 | 163701 |
| Total Cites | 12866 | 14808 |
| H-index | 61 | 66 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 3504 | 3882 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 3528 | 3911 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8999 | 9556 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.55 |
| Self-Citation Percentage |
13.11%
|
|
Robey, Robert W.
National Cancer Institute (NCI),
United States
2023 Rank: 152790
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 5791 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152790 | 159645 |
| Total Cites | 12174 | 14077 |
| H-index | 59 | 65 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 3195 | 3565 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 3215 | 3590 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8460 | 9002 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.56 |
| Self-Citation Percentage |
13.52%
|
|
Robey, Robert W.
National Cancer Institute (NCI),
United States
2022 Rank: 148766
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 5637 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148766 | 154870 |
| Total Cites | 11395 | 13201 |
| H-index | 58 | 64 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 2841 | 3186 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 2856 | 3206 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7816 | 8335 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.58 |
| Self-Citation Percentage |
13.68%
|
|